Brett James Ley MD
Critical Care Medicine, Pleural Disease
Clinical Instructor, Division of Pulmonary and Critical Care Medicine
Join to View Full Profile
505 Parnassus AveRm M-987San Francisco, CA 94143
Phone+1 415-476-1528
Dr. Ley is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am a pulmonary and critical care specialist at the Interstitial Lung Disease program at UCSF Medical Center. The multidisciplinary program includes pulmonologists, radiologists, pathologists, nurses and dedicated staff members with expertise in interstitial lung disease.
Education & Training
University of California (San Francisco)Fellowship, Pulmonary Disease and Critical Care Medicine, 2012 - 2015- University of California (San Francisco)Residency, Internal Medicine, 2008 - 2012
- University of California San Francisco School of MedicineClass of 2008
Certifications & Licensure
CA State Medical License 2010 - 2026
American Board of Internal Medicine Critical Care Medicine- American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- 17 citationsTelomere length and immunosuppression in non-idiopathic pulmonary fibrosis interstitial lung disease.David Zhang, Ayodeji Adegunsoye, Justin M Oldham, Julia Kozlitina, Nicole Garcia
The European Respiratory Journal. 2023-11-01 - 14 citationsTelomere length associates with chronological age and mortality across racially diverse pulmonary fibrosis cohorts.Ayodeji Adegunsoye, Chad A Newton, Justin M Oldham, Brett Ley, Cathryn T Lee
Nature Communications. 2023-03-17 - 4 citationsA low-cost, highly functional, emergency use ventilator for the COVID-19 crisis.Samuel J Raymond, Sam Baker, Yuzhe Liu, Mauricio J Bustamante, Brett Ley
Plos One. 2022-01-01
Press Mentions
#ATS2018 – Esbriet Lowers Risk of Seasonal IPF Flares Leading to Hospitalizations, Phase 3 Data ShowMay 29th, 2018
Bactrim for Idiopathic Pulmonary Fibrosis? Intriguing, but Not yet (RCT, Thorax)February 12th, 2016
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
